Intended for healthcare professionals


Ramipril research papers are retracted over faked data

BMJ 2015; 351 doi: (Published 21 September 2015) Cite this as: BMJ 2015;351:h5035
  1. Michael McCarthy
  1. 1Seattle

Two papers that reported that the blood pressure drug ramipril was beneficial in patients with intermittent claudication due to peripheral artery disease have been retracted after an investigation found that data were fabricated by the studies’ lead author, Anna A Ahimastos, a researcher at the prestigious Baker IDI Heart and Diabetes Institute in Melbourne, Australia.

The first paper,1 published in JAMA in …

View Full Text

Log in

Log in through your institution


* For online subscription